Literature DB >> 33660857

Neurochemical mechanisms and neurocircuitry underlying the contribution of stress to cocaine seeking.

Aaron Caccamise1, Erik Van Newenhizen2, John R Mantsch2.   

Abstract

In individuals with substance use disorders, stress is a critical determinant of relapse susceptibility. In some cases, stressors directly trigger cocaine use. In others, stressors interact with other stimuli to promote drug seeking, thereby setting the stage for relapse. Here, we review the mechanisms and neurocircuitry that mediate stress-triggered and stress-potentiated cocaine seeking. Stressors trigger cocaine seeking by activating noradrenergic projections originating in the lateral tegmentum that innervate the bed nucleus of the stria terminalis to produce beta adrenergic receptor-dependent regulation of neurons that release corticotropin releasing factor (CRF) into the ventral tegmental area (VTA). CRF promotes the activation of VTA dopamine neurons that innervate the prelimbic prefrontal cortex resulting in D1 receptor-dependent excitation of a pathway to the nucleus accumbens core that mediates cocaine seeking. The stage-setting effects of stress require glucocorticoids, which exert rapid non-canonical effects at several sites within the mesocorticolimbic system. In the nucleus accumbens, corticosterone attenuates dopamine clearance via the organic cation transporter 3 to promote dopamine signaling. In the prelimbic cortex, corticosterone mobilizes the endocannabinoid, 2-arachidonoylglycerol (2-AG), which produces CB1 receptor-dependent reductions in inhibitory transmission, thereby increasing excitability of neurons which comprise output pathways responsible for cocaine seeking. Factors that influence the role of stress in cocaine seeking, including prior history of drug use, biological sex, chronic stress/co-morbid stress-related disorders, adolescence, social variables, and genetics are discussed. Better understanding when and how stress contributes to drug seeking should guide the development of more effective interventions, particularly for those whose drug use is stress related.
© 2021 International Society for Neurochemistry.

Entities:  

Keywords:  cocaine; craving; reinstatement; relapse; seeking; stress

Mesh:

Year:  2021        PMID: 33660857      PMCID: PMC8941950          DOI: 10.1111/jnc.15340

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.546


  200 in total

1.  Stress reinstates nicotine seeking but not sucrose solution seeking in rats.

Authors:  Y Buczek; A D Lê; A Wang; J Stewart; Y Shaham
Journal:  Psychopharmacology (Berl)       Date:  1999-05       Impact factor: 4.530

2.  Sex differences in guanfacine effects on drug craving and stress arousal in cocaine-dependent individuals.

Authors:  Helen C Fox; Peter T Morgan; Rajita Sinha
Journal:  Neuropsychopharmacology       Date:  2014-01-07       Impact factor: 7.853

3.  Role of κ-Opioid Receptors in the Bed Nucleus of Stria Terminalis in Reinstatement of Alcohol Seeking.

Authors:  A D Lê; Douglas Funk; Kathleen Coen; Sahar Tamadon; Yavin Shaham
Journal:  Neuropsychopharmacology       Date:  2017-06-07       Impact factor: 7.853

4.  Cocaine dependence with and without post-traumatic stress disorder: a comparison of substance use, trauma history and psychiatric comorbidity.

Authors:  S Back; B S Dansky; S F Coffey; M E Saladin; S Sonne; K T Brady
Journal:  Am J Addict       Date:  2000

5.  Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats.

Authors:  A D Lê; S Harding; W Juzytsch; D Funk; Y Shaham
Journal:  Psychopharmacology (Berl)       Date:  2004-11-17       Impact factor: 4.530

6.  Sex differences in corticotropin releasing factor-evoked behavior and activated networks.

Authors:  Kimberly R Wiersielis; Brittany Wicks; Hannah Simko; Sarah R Cohen; Sabina Khantsis; Nausheen Baksh; David E Waxler; Debra A Bangasser
Journal:  Psychoneuroendocrinology       Date:  2016-07-28       Impact factor: 4.905

7.  The role of corticosterone in food deprivation-induced reinstatement of cocaine seeking in the rat.

Authors:  Uri Shalev; Michela Marinelli; Michael H Baumann; Pier-Vincenzo Piazza; Yavin Shaham
Journal:  Psychopharmacology (Berl)       Date:  2002-09-18       Impact factor: 4.530

8.  PTSD symptom severity as a predictor of cue-elicited drug craving in victims of violent crime.

Authors:  Michael E Saladin; David J Drobes; Scott F Coffey; Bonnie S Dansky; Kathleen T Brady; Dean G Kilpatrick
Journal:  Addict Behav       Date:  2003-12       Impact factor: 3.913

9.  Increased cortisol levels are associated with low treatment retention in crack cocaine users.

Authors:  Karina P Ligabue; Jaqueline B Schuch; Juliana N Scherer; Felipe Ornell; Vinícius S Roglio; Vanessa Assunção; Fernando P Rebelatto; Maria Paz Hildalgo; Flavio Pechansky; Felix Kessler; Lisia von Diemen
Journal:  Addict Behav       Date:  2019-12-23       Impact factor: 3.913

10.  CRF acts in the midbrain to attenuate accumbens dopamine release to rewards but not their predictors.

Authors:  Matthew J Wanat; Antonello Bonci; Paul E M Phillips
Journal:  Nat Neurosci       Date:  2013-02-17       Impact factor: 24.884

View more
  3 in total

1.  Psychosocial Factors Predict the Level of Substance Craving of People with Drug Addiction: A Machine Learning Approach.

Authors:  Hua Gong; Chuyin Xie; Chengfu Yu; Nan Sun; Hong Lu; Ying Xie
Journal:  Int J Environ Res Public Health       Date:  2021-11-19       Impact factor: 3.390

2.  Networks of habenula-projecting cortical neurons regulate cocaine seeking.

Authors:  Victor P Mathis; Maya Williams; Clementine Fillinger; Paul J Kenny
Journal:  Sci Adv       Date:  2021-11-05       Impact factor: 14.136

3.  BDNF and Cortisol in the Diagnosis of Cocaine-Induced Depression.

Authors:  Francina Fonseca; Joan Ignasi Mestre-Pinto; Rocío Rodríguez-Minguela; Esther Papaseit; Clara Pérez-Mañá; Klaus Langohr; Margherita Barbuti; Magí Farré; Marta Torrens
Journal:  Front Psychiatry       Date:  2022-03-15       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.